Xilio Therapeutics, Inc. Contracts & Agreements
46 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (3)
- Human Resources (20)
- Intellectual Property (3)
- Real Estate (1)
- Uncategorized (7)
- Third Amended and Restated Employment Agreement, dated August 3, 2024, by and between the Registrant and Christopher Frankenfield (Filed With SEC on August 8, 2024)
- License Agreement, dated March 27, 2024, between Xilio Development, Inc. and Gilead Sciences, Inc (Filed With SEC on May 14, 2024)
- Common Stock Purchase Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc (Filed With SEC on May 14, 2024)
- Investor Rights Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc (Filed With SEC on May 14, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 14, 2024)
- Employment Agreement, dated September 5, 2023, by and between the Registrant and Katarina Luptakova, M.D (Filed With SEC on April 1, 2024)
- Form of Prefunded Warrant (Filed With SEC on March 28, 2024)
- Securities Purchase Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto (Filed With SEC on March 28, 2024)
- Registration Rights Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto (Filed With SEC on March 28, 2024)
- Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan (Filed With SEC on January 3, 2024)
- Consulting Agreement, dated September 8, 2023, by and between the Registrant and Martin Huber, M.D (Filed With SEC on November 9, 2023)
- Employment Agreement, dated September 5, 2023, by and between Xilio Therapeutics, Inc. and Kevin Brennan (Filed With SEC on September 5, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 14, 2023)
- Second Amended and Restated Employment Agreement, dated August 3, 2023, by and between the Company and Christopher Frankenfield (Filed With SEC on August 3, 2023)
- Amended and Restated Loan and Security Agreement, dated as of May 5, 2023, by and between Xilio Development, Inc. and Pacific Western Bank (Filed With SEC on May 9, 2023)
- Offer Letter, dated March 15, 2023, by and between Xilio Therapeutics, Inc. and Kevin Brennan (Filed With SEC on April 3, 2023)
- 2022 Inducement Stock Incentive Plan (Filed With SEC on March 2, 2023)
- Form of Stock Option Agreement under the 2022 Inducement Stock Incentive Plan (Filed With SEC on March 2, 2023)
- Form of Restricted Stock Unit Agreement under the 2022 Inducement Stock Incentive Plan (Filed With SEC on March 2, 2023)
- Amended and Restated Employment Agreement, dated June 15, 2022, by and between the Registrant and Martin Huber, M.D (Filed With SEC on June 16, 2022)
- Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank (Filed With SEC on May 12, 2022)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 1, 2022)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Salvatore Giovine (Filed With SEC on March 1, 2022)
- Form of Underwriting Agreement (Filed With SEC on October 18, 2021)
- 2021 Stock Incentive Plan (Filed With SEC on October 18, 2021)
- Form of Stock Option Agreement under the 2021 Stock Incentive Plan (Filed With SEC on October 18, 2021)
- Form of Non-Employee Director Stock Option Agreement under the 2021 Stock Incentive Plan (Filed With SEC on October 18, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on October 18, 2021)
- SERVICE AGREEMENT (Filed With SEC on October 18, 2021)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on October 1, 2021)
- Amended and Restated Registration Rights Agreement, dated as of February 23, 2021, by and among the Registrant and the other parties thereto (Filed With SEC on October 1, 2021)
- 2020 Stock Incentive Plan, as amended (Filed With SEC on October 1, 2021)
- Form of Stock Option Agreement under 2020 Stock Incentive Plan (Filed With SEC on October 1, 2021)
- Form of Restricted Stock Agreement under 2020 Stock Incentive Plan (Filed With SEC on October 1, 2021)
- Director Compensation Policy (Filed With SEC on October 1, 2021)
- Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank (Filed With SEC on October 1, 2021)
- Cross-License Agreement, dated as of December 16, 2020, by and between the Registrant and AskGene Pharma, Inc (Filed With SEC on October 1, 2021)
- Amended and Restated Exclusive License Agreement, dated as of August 16, 2016, by and between the Registrant and City of Hope (Filed With SEC on October 1, 2021)
- License Agreement, dated as of September 26, 2016, as amended, by and between the Registrant and WuXi Biologics (Hong Kong) Limited (Filed With SEC on October 1, 2021)
- Lease, dated as of August 26, 2019, as amended, by and between the Registrant and PPF off 828-830 Winter Street, LLC (Filed With SEC on October 1, 2021)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Ren Russo (Filed With SEC on October 1, 2021)
- Letter Agreement, dated May 24, 2019, by and between the Registrant and Joseph Farmer (Filed With SEC on October 1, 2021)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Martin Huber (Filed With SEC on October 1, 2021)
- Separation Agreement, dated March 12, 2021, by and between the Registrant and Joseph Farmer (Filed With SEC on October 1, 2021)
- Service Agreement, dated June 11, 2020, by and between the Registrant and Daniel S. Lynch (Filed With SEC on October 1, 2021)
- Form of Indemnification Agreement between the Registrant and each of its Executive Officers and Directors (Filed With SEC on October 1, 2021)
